Ann: Investor Presentation - March 2023, page-360

Too many uncertainties. There are numerous things that will push the share price forwards;
Increased profitability from the quarterly (there will be higher R&D costs but as long as the ratio between operating expenses and costs is moving in the right direction that will be bullish
More commercial deals, as well as commercial details about the deals - lots of promise here but the "big 5 contract" is pie in the sky until the details are made public. The Nviso deal also looks promising, but then so did the Pangeamed and Srcflare deals of last year which have now disappeared in a puff of smoke.
Real wow factor from the talking heads - these show improvement but the lack of conversational ability on the website was a big let-down - with only the 5 preset question options we have no way of knowing if they are genuinely able to carry an AI conversation.
The potential here is massive but there are still too many risks and uncertainties for a re-rating yet. If the ambitious plan in the investor presso can be stuck to, hopefully we won't have to wait too long.